Skip to main content
Top
Published in: Rheumatology International 12/2011

01-12-2011 | Original Article

P wave dispersion in familial Mediterranean fever

Authors: Naomi Nussinovitch, Avi Livneh, Keren Katz, Moshe Nussinovitch, Benjamin Volovitz, Merav Lidar, Udi Nussinovitch

Published in: Rheumatology International | Issue 12/2011

Login to get access

Abstract

Familial Mediterranean fever (FMF) is a hereditary disease characterized by recurrent and self-terminated attacks of fever and polyserositis. A recent study found that FMF patients had an abnormally high P wave duration and P wave dispersion, markers for supraventricular arrhythmogenicity. The aim of our study was to further evaluate atrial dispersion in FMF patients. The study group consisted of 26 patients with uncomplicated FMF and age- and sex-matched control subjects. All participants underwent 12-lead electrocardiography under strict standards. P wave length and P wave dispersion were computed from a randomly selected beat and from an averaged beat constructed from 7 to 12 beats, included in a 10-s ECG. No statistically significant differences were found between the groups in minimal, maximal, and average P wave duration and P wave dispersion calculated either from a random beat or averaged beats. During 6 months of follow-up, no supraventricular arrhythmias were documented in either group. FMF patients who are continuously treated with colchicine and do not develop amyloidosis have normal atrial conduction parameters and therefore seemingly do not have an increased electrocardiographic risk of atrial fibrillation.
Literature
3.
go back to reference Michelucci A, Bagliani G, Colella A, Pieragnoli P, Porciani MC, Gensini G, Padeletti L (2002) P wave assessment: state of the art update. Card Electrophysiol Rev 6:215–220PubMedCrossRef Michelucci A, Bagliani G, Colella A, Pieragnoli P, Porciani MC, Gensini G, Padeletti L (2002) P wave assessment: state of the art update. Card Electrophysiol Rev 6:215–220PubMedCrossRef
4.
go back to reference Perzanowski C, Ho AT, Jacobson AK (2005) Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J Electrocardiol 38:43–46PubMedCrossRef Perzanowski C, Ho AT, Jacobson AK (2005) Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J Electrocardiol 38:43–46PubMedCrossRef
5.
go back to reference Acar G, Akcay A, Sayarlioglu M, Sokmen A, Sokmen G, Koroglu S, Gunduz M, Ispiroglu M, Tuncer C (2009) Assessment of atrial conduction time in patients with familial Mediterranean fever. Pacing Clin Electrophysiol 32:308–313PubMedCrossRef Acar G, Akcay A, Sayarlioglu M, Sokmen A, Sokmen G, Koroglu S, Gunduz M, Ispiroglu M, Tuncer C (2009) Assessment of atrial conduction time in patients with familial Mediterranean fever. Pacing Clin Electrophysiol 32:308–313PubMedCrossRef
6.
go back to reference Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef
7.
go back to reference Kose S, Aytemir K, Can I, Iyisoy A, Kilic A, Amasyali B, Kursaklioglu H, Isik E, Oto A, Demirtas E (2002) Seasonal variation of P-wave dispersion in healthy subjects. J Electrocardiol 35:307–311PubMedCrossRef Kose S, Aytemir K, Can I, Iyisoy A, Kilic A, Amasyali B, Kursaklioglu H, Isik E, Oto A, Demirtas E (2002) Seasonal variation of P-wave dispersion in healthy subjects. J Electrocardiol 35:307–311PubMedCrossRef
8.
go back to reference Gasparyan AY, Ugurlucan M (2008) The emerging issue of cardiovascular involvement in familial Mediterranean fever. Arch Med Sci 4:465–467 Gasparyan AY, Ugurlucan M (2008) The emerging issue of cardiovascular involvement in familial Mediterranean fever. Arch Med Sci 4:465–467
9.
go back to reference Yuksel S, Ayvazyan L, Gasparyan AY (2010) Familial Mediterranean fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. Open Cardiovasc Med J 4:51–56PubMed Yuksel S, Ayvazyan L, Gasparyan AY (2010) Familial Mediterranean fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. Open Cardiovasc Med J 4:51–56PubMed
10.
go back to reference Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2009) Heart rate variability in familial Mediterranean fever. Rheumatol Int Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2009) Heart rate variability in familial Mediterranean fever. Rheumatol Int
11.
go back to reference Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M (1994) Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 37:1804–1811PubMedCrossRef Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M (1994) Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 37:1804–1811PubMedCrossRef
Metadata
Title
P wave dispersion in familial Mediterranean fever
Authors
Naomi Nussinovitch
Avi Livneh
Keren Katz
Moshe Nussinovitch
Benjamin Volovitz
Merav Lidar
Udi Nussinovitch
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1508-0

Other articles of this Issue 12/2011

Rheumatology International 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.